<DOC>
	<DOCNO>NCT01603849</DOCNO>
	<brief_summary>Lung cancer first cause death among cancer patient . Non Small Cell lung cancer ( NSCLS ) represent 80-85 % case . Of , 80 % present locally advance metastatic disease . Important mention number patient progress recur central nervous system ( CNS ) . It report patient adenocarcinoma , 60 year elevate carcinoembryonic antigen ( CEA ) high risk develop brain metastasis . In small cell lung cancer , treatment prophylactic cranial irradiation ( PCI ) standard care patient without progression locoregional systemic treatment proven benefit overall survival ( OS ) progression free survival ( PFS ) . However , NSCLC PCI able prove survival benefit , CNS PFS , probably trial , knowledge , PCI NSCLC include specific group patient consider high risk develop brain metastasis .</brief_summary>
	<brief_title>Prophylactic Cranial Irradiation Patients With Lung Adenocarcinoma With High Risk Brain Metastasis</brief_title>
	<detailed_description>Objectives : 1 . To obtain great PFS CNS PFS patient NSCLC treat PCI locoregional systemic treatment . 2 . Evaluate benefit OS specific group patient increase risk develop brain metastasis 3 . Evaluate quality life mental function treatment PCI compare patient observation group . Methods : One hundred twenty eight patient locally advanced metastatic ( except CNS metastasis ) NSCLC include randomize receive either observation PCI 25 Gy 10 fraction Whole Brain Radiotherapy ( WBRT ) initial treatment complete progression disease rule .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<criteria>Patients histologically proven advanced NSCLC ( Stage IIIB IV ) receive treatment either locoregional systemic without progression end . Above 18 year 60 year age General status Karnofsky &gt; 80 % Eastern Cooperative Group ( ECOG ) â‰¤2 Negative CNS MRI begin treatment Carcinoembryonic antigen &gt; 20 ng/mL Hepatic hematic cytology test within normal range Adequate renal function Those accept participate study sign letter inform consent . Patients another type cancer Patients refuse participate protocol General status Karnofsky &lt; 80 % Eastern Cooperative Group ( ECOG ) &gt; 2 Previous treatment WBRT Previous treatment chemotherapy Disease progression initial treatment , either chemotherapy chemoradiotherapy depend case . CNS metastasis diagnosis Carcinoembryonic antigen &lt; 20 ng/mL Abnormal laboratory test interfere chemotherapy administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prophylactic Cranial Irradiation</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>Carcinoembryonic Antigen</keyword>
</DOC>